Navigation Links
NeurogesX to Present at Roth 2008 OC Growth Stock Conference
Date:2/19/2008

believes offers significant advantages over other pain therapies. Three Phase 3 clinical trials with NGX-4010 have been completed and have met their primary endpoints, two in PHN and one in painful HIV-DSP.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, the timing of presentations by NeurogesX and the expected benefits of NeurogesX' potential products, including its lead product candidate NGX-4010. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, past results of clinical trials may not be indicative of future clinical trials results; NeurogesX' product candidate may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA or European regulatory approval; physician or patient reluctance to use NGX-4010, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in clinical development, obtaining regulatory approval, market acceptance and commercialization of NGX-4010 and the advantages of NGX-4010 over other pain therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

NeurogesX The Ruth Group

Steph
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
2. NeurogesX Closes $25 Million Private Placement
3. NeurogesX, Inc. Announces $25 Million Private Placement
4. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX Expands Senior Management Team
7. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
8. NeurogesX Appoints New Director to the Board
9. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
10. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
11. AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 The new Public-Private Partnership ... at the association’s recent annual meeting drew praise from ... Neelie Kroes, who called the action “a huge step ... stimulant to European innovation.” , The Board of Stakeholders ... new Photonics PPP at its 29 April meeting in ...
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., ... needs in epilepsy and related neurological disorders, is today ... its lead compound INS001 in patients with drug-resistant epilepsy.  ... and Device Trials (AED) Xll meeting by Dr. ... and Chairman of Insero,s Scientific Advisory Board.  In this ...
(Date:5/17/2013)... RURO Inc. is pleased to ... versatile refinement to the smart management solution. , ... advanced methodical management for transgenic animal colonies, genotyping ... network-based platform provides user access with a plethora ... to emphasize streamlined tasks, such as animal relocation ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2
... VIEW, Calif., May 5 ChemoCentryx, Inc., today ... small molecule antagonist of the C5a receptor, CCX168, ... acceptance of the molecule as a development candidate ... alliance with GlaxoSmithKline (NYSE: GSK ). ...
... May 5 UV germicidal lamps have been used ... airborne respiratory illnesses in schools and hospitals since the ... in Mexican schools during a 1955 Mumps epidemic and ... York that same year. More recently, UVGI units were ...
... Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) provides an ... Worldwide Sales and Distribution Update, - ... of two, additional marketing and ... recognized backgrounds in the nutraceutical and functional food, ...
Cached Biology Technology:ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 3ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 4Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again 2Neptune Product and Distribution Update 2Neptune Product and Distribution Update 3Neptune Product and Distribution Update 4
(Date:5/17/2013)... An international team of scientists using ... cell movement inside a living frog embryo in greater ... method to advance biological research and the search for ... and the Karlsruher Institut fr Technologie in Germany, in ... Department of Energy,s Argonne National Laboratory, released the most ...
(Date:5/16/2013)... have used ancient shorelines to predict the stability of today,s ... high shoreline from three million years ago, for example ... thought to be evidence of a high sea level due ... led many scientists to think that if the world,s largest ... just the same in our modern, progressively warming world. ...
(Date:5/16/2013)... players and athletes choose to wear the color red ... in Psychological Science , a journal of the ... to do with their testosterone levels. , The new ... University of Sunderland and colleagues, demonstrated that males who ... had higher testosterone levels than other males who chose ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2World's biggest ice sheets likely more stable than previously believed 2High-testosterone competitors more likely to choose red 2
... a baby is usually a joyous event, but when a child ... problems for the baby and steep medical bills for the family. ... have invented a new system to pick up very early signs ... normal length of a pregnancy is 40 weeks, while babies born ...
... -- Can HIV infection ever be cured? The prospect ... the topic of a high-level, two-day meeting of researchers ... biennial international conference of HIV researchers, funders, policy-makers and ... and Strategies to Control Them," brought together basic scientists, ...
... have provided a new solution to an old debate on why ... study to be published online next week in the online open ... of genetic "noise" caused by a surprising degree of variation in ... They found that when species hybridise, some of the variation in ...
Cached Biology News:Students design early labor detector to prevent premature births 2Students design early labor detector to prevent premature births 3Students design early labor detector to prevent premature births 4Top scientists tackle the issue of HIV persistence 2What causes hybrid vigor? 2
This free-standing laminar flow hood provides a horizontal flow of HEPA-filtered air to create a clean processing area. Air return slots along the front and side edges of the work area enhance system...
... B3 series of microscopes offer all of ... for laboratory work. Equipped with Koehler illumination, ... (ASC) objectives. The B3 is the workhorse ... binocular tube eliminates the need for re-focusing ...
... control for microbiology and cell culture. The ... suitable for DASGIP bioreactors from 150 mL ... ranges from approximately 10 °C to 60 ... an individual electrical heating element with integrated ...
RORgamma (S-14)...
Biology Products: